Pernix Therapeutics (PTX) Govt Affairs Executive Wins Pain Management Advocacy Award

September 16, 2016 7:28 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Pernix Therapeutics Holdings, Inc. (Nasdaq: PTX) announced that Marsha Stanton, Ph.D., RN, Executive Director of Medical and Government Affairs, was awarded the prestigious Pain Management Advocacy Award from the American Society for Pain Management Nursing® (ASPMN) at the 2016 ASPMN National Conference, which was held in Louisville, KY, from September 7-10, 2016.

“We are proud of Dr. Stanton’s recognition at the ASPMN national conference, and are very pleased to have someone of her caliber as a member of the Pernix Therapeutics team,” said John Sedor, Chairman and CEO of Pernix Therapeutics.

Nominees for the Pain Management Advocacy Award must demonstrate leadership and outstanding contributions which have influenced public perception, attitudes, and awareness of pain and its management through public education, governmental reform, and/or media exposure compatible with the ASPMN mission and goals.

Dr. Stanton is nationally recognized for her extensive work in pain management, including clinical practice, public policy and patient education. She is a registered nurse, and obtained her Master of Science in Health & Human Services from Columbia Pacific University and a Ph.D. in Health Education from Glendale University.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Comments

Related Entities


Add Your Comment